If anything, I would have thought the SRX announcement is a positive for OSL. SRX got a positive outcome for PFS for the liver, which is where they're dosing the spheres.
The patients had metastatic colorectal cancer with secondary tumours potentially in the lungs and lymph nodes as well as primary in the liver. The announcement seems to say what you'd expect.... that it helped the tumours in the liver but pts experienced progression elsewhere.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.16 |
Change
-0.070(5.69%) |
Mkt cap ! $16.49M | |||
| Open | High | Low | Value | Volume |
| $1.25 | $1.25 | $1.11 | $72.36K | 60.96K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9286 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.18 | 412 | 1 |
View Market Depth
| Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
| OSL (ASX) Chart |